The Madison-based venture capital firm, which raised $69 million in the initial closing, said the additional funding places Early Stage Fund IV among the largest Midwest-focused, early-stage venture capital funds.
John Neis, managing director of Venture Investors, said the fund would continue to focus on investments during the formative stages of technology and biotechnology companies that have spun out of leading research institutions in Wisconsin, Michigan, and the Midwest.
Joe Vanden Plas
Full Story: http://wistechnology.com/article.php?id=4045